Skip to main content
. 2024 Nov 8;27(12):111344. doi: 10.1016/j.isci.2024.111344

Table 1.

Characteristics of the Singapore Epidemiology of Eye Diseases study participants according to lipid-lowering drug

No LLD
LLD
p value ASD
n = 4,328 n = 1,251
Age, years, median (IQR) 52.8 (48.0, 60.2) 61.1 (54.3, 66.9) <0.001 0.73
Female, n (%) 2,260 (52.2) 622 (49.7) 0.119 0.05
Ethnicity, n (%) <0.001 0.31
 Chinese 1,704 (39.4) 490 (39.2)
 Indian 1,292 (29.9) 523 (41.8)
 Malay 1,332 (30.8) 238 (19.0)
Hypertension, n (%) 2,131 (49.4) 1,018 (81.4) <0.001 0.72
Diabetes, n (%) 727 (16.8) 595 (47.6) <0.001 0.70
BMI, kg/m2, median (IQR) 24.6 (22.0, 27.6) 25.5 (23.2, 28.5) <0.001 0.24
Smoking status, n (%) <0.001 0.13
 Never smoked 3,094 (71.5) 925 (74.0)
 Current smoker 689 (15.9) 147 (11.8)
 Past smoker 542 (12.5) 178 (14.2)
CVD, n (%) 156 (3.6) 262 (20.9) <0.001 0.55
Education level, n (%) <0.001 0.16
 No or primary 2,205 (51.0) 736 (59.0)
 Higher than primary 2,118 (49.0) 512 (41.0)

LLD, lipid-lowering drug; IQR, interquartile range; ASD, absolute standardized difference; BMI, body mass index; CVD, cardiovascular disease.